A Chromatographic Method Development and Validation for Tofacitinib Citrate and Baricitinib Using RGB And GREEN Pech
International Journal of Drug Delivery Technology · 13.07.2026 · 16 (65s)
DOI: 10.25258/ijddt.16.65s.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.07.2026. Verfasst von Samruddhi Bornare und 6 weiteren Autor:innen.
Abstract (Originalsprache)
A simple, sensitive, precise, accurate, and environment-friendly reversed-phase high-performance liquid chromatographic (RP-HPLC) method has been developed and validated for the simultaneous estimation of tofacitinib citrate and baricitinib. The chromatographic separation was achieved on a Phenomenex Luna C18 column (250 × 4.6 mm, 5 μm) using a mobile phase consisting of acetonitrile and ammonium acetate buffer (pH 4.5) in the ratio of 40:60 (v/v), delivered at a flow rate of 1.0 mL/min. Detection was performed at 285 nm using a UV detector. The retention times of tofacitinib citrate and baricitinib were found to be 4.12 ± 0.03 min and 6.87 ± 0.04 min, respectively, under optimized conditions. The developed method was validated in accordance with the International Conference on Harmonisation (ICH) Q2(R1) guidelines, covering parameters including specificity, linearity, accuracy, precision, limits of detection (LOD) and quantification (LOQ), robustness, and solution stability. Linearity was observed over the concentration range of 5–30 μg/mL for tofacitinib citrate (r² = 0.9998) and 2–12 μg/mL for baricitinib (r² = 0.9997). Mean percent recovery values ranged from 98.6–101.2% for tofacitinib citrate and 99.1–100.8% for baricitinib, confirming excellent accuracy. Precision values expressed as %RSD were below 2.0% for both intra-day and inter-day studies. The greenness profile of the method was evaluated using four complementary tools: NEMI (National Environmental Methods Index), GAPI (Green Analytical Procedure Index), AGREE (Analytical GREEnness Metric), and the EcoScale scoring system. The AGREE score was 0.72, and the Eco-Scale score was 78 (categorized as 'Acceptable Green Method'), indicating that the method is significantly more environmentally friendly compared to previously reported methods. The validated method was successfully applied for the assay of commercially available pharmaceutical formulations, yielding results well within acceptable limits. This method offers a reliable, costeffective, and green alternative for routine quality control analysis of tofacitinib citrate and baricitinib in pharmaceutical dosage forms.
Zitieren
APA
Bornare, S., Jain, U., Jain, N., Aglawe, S., Kawade, D., Badhe, P., & Dawange, S. (2026). A Chromatographic Method Development and Validation for Tofacitinib Citrate and Baricitinib Using RGB And GREEN Pech. International Journal of Drug Delivery Technology, 16(65s). https://doi.org/10.25258/ijddt.16.65s.13
Vancouver
Bornare S, Jain U, Jain N, Aglawe S, Kawade D, Badhe P, et al. A Chromatographic Method Development and Validation for Tofacitinib Citrate and Baricitinib Using RGB And GREEN Pech. International Journal of Drug Delivery Technology. 2026;16(65s). doi:10.25258/ijddt.16.65s.13
BibTeX
@article{Bornare2026,
author = {Bornare, Samruddhi and Jain, Usha and Jain, Nitin and Aglawe, Sachin and Kawade, Dadasaheb and Badhe, Pratiksha and Dawange, Sakshi},
title = {A Chromatographic Method Development and Validation for Tofacitinib Citrate and Baricitinib Using RGB And GREEN Pech},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {65s},
doi = {10.25258/ijddt.16.65s.13}
}
EUVIMED